Inhaled CVT301 in Subjects with Parkinson's Disease

• Research type

  Research Study

• Full title

  A Phase 2b, Randomized, Double-blind, Placebo-controlled Study Investigating the Efficacy and Safety of Inhaled CVT 301 (Levodopa Inhalation Powder) in Parkinson’s Disease Patients With Motor Response Fluctuations (OFF Phenomena)

• IRAS ID

  124357

• Contact name

  Donald Grosset

• Contact email

  donaldgrosset@gmail.com

• Sponsor organisation

  Civitas Therapeutics, Inc.

• Eudract number

  2012-005822-31

• Clinicaltrials.gov Identifier

  NCT01777555

• REC name

  North West - Greater Manchester South Research Ethics Committee

• REC reference

  13/NW/0171

• Date of REC Opinion

  18 Apr 2013

• REC opinion

  Further Information Favourable Opinion